Fig. 2From: Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinomaThe association between SEMA4B expression and clinical characteristics, including (A) TNM stage, (B) gender, age and smoke status. (C) A nomogram for predicting LUAD patients the probability of 1-, 3-, and 5- year OS. SP, Survival Probability. (D) Calibration plots of the nomogram. (E) Survival curves of OS between high and low SEMA4B expression in LUADBack to article page